United States · FDA National Drug Code directory
SPEVIGO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0597-7705_021b29b5-64ea-411e-91a8-c1f5015c3d9c
- Product NDC
- 0597-7705
- Form
- INJECTION
- Composition / generic term
- spesolimab-sbzo
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250528 / 20270430
Source-listed ingredients
- SPESOLIMAB — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (0597-7705-41) / 300 INJECTION in 1 SYRINGE (0597-7705-38) · 0597-7705-41
- 2 SYRINGE in 1 CARTON (0597-7705-72) / 300 INJECTION in 1 SYRINGE (0597-7705-38) · 0597-7705-72
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →